Beauty Farm Medical and Health Industry Inc. repurchased 43,500 ordinary shares on 26 June 2026, spending HK$0.69 million at prices ranging from HK$15.84 to HK$16.01 per share, equivalent to a volume-weighted average of HK$15.94 per share.

The transaction reduced the company’s outstanding share count by 0.02 % to 248.48 million shares, while increasing treasury stock to 3.12 million shares. Total issued share capital remained unchanged at 251.59 million shares, as the bought-back shares are being held in treasury.

The repurchase utilised 0.02 % of the 24.85 million-share mandate approved by shareholders on 26 June 2026. In accordance with Hong Kong Stock Exchange rules, the company is under a moratorium on issuing new shares or disposing of treasury shares until 26 July 2026.

Director Li Yang confirmed all regulatory and corporate authorisations for the transaction were duly obtained, and that the buyback complied with Main Board Rule 10.06 and related provisions.